Multiple Myeloma
Mostrando 1-12 de 331 artigos, teses e dissertações.
-
1. Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents – a retrospective analysis
Abstract BACKGROUND: In this era of target therapies, novel data on the correlation between response endpoints and survival outcomes in multiple myeloma have arisen. OBJECTIVE: To determine the impact of quality of response on clinical outcomes, using first-line treatment, and identify risk factors influencing progression-free survival (PFS) and overall su
Sao Paulo Medical Journal. Publicado em: 2022
-
2. Oral manifestations of systemic amyloidosis, an aid to diagnosis of multiple myeloma - report of two cases
Brazilian Journal of Otorhinolaryngology. Publicado em: 2022
-
3. Guidelines on the diagnosis and management of multiple myeloma treatment: Associac ao Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
4. Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? - Literature review
ABSTRACT Introduction Multiple myeloma is a progressive and incurable hematological disease characterized by disordered and clonal multiplication of plasmacytes in the bone marrow. The main clinical manifestations are caused by the presence of neoplastic cells in bone tissue, as well as the excessive production of immunoglobulins and normal humoral immunity
Hematol., Transfus. Cell Ther.. Publicado em: 2021-06
-
5. Second COVID-19 infection in a patient with multiple myeloma in Brazil - reinfection or reactivation?
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved i
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
6. Spontaneous spleen rupture: an unusual presentation of extramedullary multiple myeloma
Resumo Nosso objetivo foi analisar a associação entre depressão previamente diagnosticada e alterações na atividade física (AF), tempo assistindo TV, consumo de frutas e vegetais, bem como na frequência do consumo de alimentos ultraprocessados (AUP). Foram utilizados dados de 41.923 adultos brasileiros (6.881 com depressão e 35.042 sem depressão) de
Hematol., Transfus. Cell Ther.. Publicado em: 2020-10
-
7. Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe
ABSTRACT Since the World has been facing the COVID-19 pandemic, special attention has been taken concerning cancer patients; related to their immunosuppression status, adding risk for more aggressive COVID-19 and mortality, but also concerns about the access and the quality of care in cancer therapy. The COVID-19 pandemic impacts the number of infected, its
Hematol., Transfus. Cell Ther.. Publicado em: 2020-09
-
8. Oral health status of patients with multiple myeloma
ABSTRACT Objective: To describe the oral health status of patients with multiple myeloma and compare to a control group. Materials and methods: The medical history of the studied subjects was obtained from the medical records and through interviews. Trained examiners evaluated the oral mucosa, teeth, periodontium and imaging aspects. The dental status was
Hematol., Transfus. Cell Ther.. Publicado em: 2020-06
-
9. Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
ABSTRACT Background: The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival. Studies comparing different induction chemotherapy regimens have shown that triple combinations have better results than double combinations. However, comparisons among d
Hematol., Transfus. Cell Ther.. Publicado em: 2020-06
-
10. Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
ABSTRACT Background: Bone marrow angiogenesis is increased in multiple myeloma (MM) patients, prompting the rationale for using antiangiogenic drugs in the treatment of these patients. Objective: To assess angiogenesis in patients with MM at diagnosis and following treatment with an antiangiogenic drug. Patients and Methods: Twenty-three patients with new
Hematol., Transfus. Cell Ther.. Publicado em: 2020-06
-
11. A case of multiple myeloma and synchronous liposarcoma
Abstract Introduction Hematologists deal every day with high mortality rates of acute leukemia patients. Many times these patients need Intensive Care Unit (ICU) support and some general ICU teams believe that these patients have a much greater chance of dying than patients with other pathologies. In Brazil, data related to mortality rates and ICUs for acut
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
12. Spontaneous splenic rupture associated with multiple myeloma: a serious and unusual case
Abstract Introduction Patients with benign or malignant blood disorders, who require allogeneic stem cell transplantation and lack an identical human leukocyte antigen HLA identicalHL sibling donor, could be transplanted with hematopoietic stem cells from unrelated adult or umbilical cord donors. However, in our country, both approaches are costly and time-
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03